Cosmegen and microangiopathy Patient Reports February 12, 2012

Cosmegen Side Effects Report #6009093-1
Cosmegen side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2008. Male patient was diagnosed with fibrosarcoma and was treated with Cosmegen. After drug was administered, patient experienced the following side effects: bone marrow failure, microangiopathy. Cosmegen dosage: unknown. During the same period patient was treated with ONCOVIN. Patient was hospitalized. Patient recovered.

Cosmegen Side Effects Report #6051369-6
Cosmegen side effect was reported by a Consumer or non-health professional from JAPAN on Jan 06, 2009. Male patient was diagnosed with fibrosarcoma and was treated with Cosmegen. After drug was administered, patient experienced the following side effects: angiopathy, bone marrow failure, microangiopathy, poor sucking reflex, pyrexia, urine output decreased, vomiting. Cosmegen dosage: 0.045 MG; IV 0.07 MG; IV 0.045 MG; IV. During the same period patient was treated with ONCOVIN, DOXORUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE, ETOPOSIDE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Cosmegen Side Effects Report #6081485-4
Cosmegen side effect was reported by a Consumer or non-health professional from JAPAN on Jan 30, 2009. Male patient, weighting 13.23 lb, was diagnosed with fibrosarcoma and was treated with Cosmegen. After drug was administered, patient experienced the following side effects: bone marrow failure, microangiopathy, poor sucking reflex, pyrexia, renal impairment, urine output decreased, vomiting. Cosmegen dosage: 0.045MG; IV; 0.07 MG; IV; 0.045 MG; IV. During the same period patient was treated with ONCOVIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.